Skip to main content
. Author manuscript; available in PMC: 2020 Dec 29.
Published in final edited form as: Target Oncol. 2019 Oct;14(5):613–618. doi: 10.1007/s11523-019-00661-5

Table 2.

Dose escalation

Dose (mg/m2) Increase from prior dose
level
Number
of patients
treated
120 1
200 67% 1
330 65% 1
500 52% 1
750 50% 2a
1050 40% 1
1470 40% 1
2060 40% 6
a

One patient replaced due to disease progression on cycle 1 day 2 (new brain metastases)